BCRX
BioCryst Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
4.08 / 10Overall Score
NeturalInvestment Rating
4.08 / 10Overall Score
NeturalInvestment Rating
Will BCRX Go Up?
- Based on a composite score of 4.08/10, we rate BCRX as a Netural. Our analysis breaks down into 3.11/10 for Fundamentals, 2.52/10 for Technicals, and 5.34/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for BCRX?
Is BCRX fundamentally strong?
What is the analyst consensus for BCRX?
Will BCRX Go Up?
- Based on a composite score of 4.08/10, we rate BCRX as a Netural. Our analysis breaks down into 3.11/10 for Fundamentals, 2.52/10 for Technicals, and 5.34/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is BCRX fundamentally strong?
What is the current technical signals for BCRX?
What is the analyst consensus for BCRX?
